“`html
Study Summary
The study aimed to assess the effectiveness of using urine samples to detect high-grade cervical precancer (CIN2+) caused by human papillomavirus (HPV) using two different urine collection devices.
Key Findings
- The sensitivity of HPV testing in urine samples collected with the FVU-collection device was 90.3%, higher than the standard pot which had a sensitivity of 73.4%.
- Urine collected with the FVU-collection device showed promising sensitivity for CIN2+ detection.
- Participants found urine self-sampling to be acceptable.
Practical Implications
- Using the FVU-collection device for urine sampling can improve the detection of high-grade cervical precancer.
- Urine-based testing using the FVU-collection device could be a potential alternative to routine cervical screening in the future.
“`
